Norris Perne & French LLP Johnson & Johnson Transaction History

Norris Perne & French LLP

$1.36 Billion
Q3 2024

A detailed history of Norris Perne & French LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Norris Perne & French LLP holds 187,222 shares of JNJ stock, worth $27.3 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares

187,222

Previous 154,204 21.41%

Holding current value

$27.3 Million

Previous $22.5 Million 34.62%

% of portfolio

2.23%

Previous 1.74%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$145.48 - $167.38 $4.8 Million - $5.53 Million	33,018 Added 21.41%	187,222 $30.3 Million
Q2 2024 Jul 24, 2024	BUY	$144.38 - $157.78 $6.77 Million - $7.4 Million	46,876 Added 43.68%	154,204 $22.5 Million
Q1 2024 Apr 16, 2024	BUY	$155.22 - $162.74 $652,389 - $683,996	4,203 Added 4.08%	107,328 $17 Million
Q4 2023 Jan 22, 2024	BUY	$145.6 - $158.88 $605,259 - $660,464	4,157 Added 4.2%	103,125 $16.2 Million
Q3 2023 Oct 18, 2023	BUY	$155.75 - $174.48 $298,417 - $334,303	1,916 Added 1.97%	98,968 $15.4 Million
Q2 2023 Jul 19, 2023	BUY	$154.35 - $166.11 $677,905 - $729,555	4,392 Added 4.74%	97,052 $16.1 Million
Q1 2023 Apr 20, 2023	BUY	$151.05 - $180.26 $740,296 - $883,454	4,901 Added 5.58%	92,660 $14.4 Million
Q4 2022 Jan 24, 2023	BUY	$160.2 - $179.79 $322,803 - $362,276	2,015 Added 2.35%	87,759 $0
Q3 2022 Oct 13, 2022	BUY	$161.33 - $179.52 $236,671 - $263,355	1,467 Added 1.74%	85,744 $14 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $8.81 Million - $9.74 Million	-52,381 Reduced 38.33%	84,277 $15 Million
Q1 2022 Apr 26, 2022	SELL	$158.14 - $179.59 $128,251 - $145,647	-811 Reduced 0.59%	136,658 $24.2 Million
Q4 2021 Jan 26, 2022	SELL	$155.93 - $173.01 $2.07 Million - $2.3 Million	-13,306 Reduced 8.83%	137,469 $23.5 Million
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $42,474 - $47,200	-263 Reduced 0.17%	150,775 $24.4 Million
Q2 2021 Jul 20, 2021	BUY	$159.48 - $171.07 $300,300 - $322,124	1,883 Added 1.26%	151,038 $24.9 Million
Q1 2021 Apr 30, 2021	SELL	$153.07 - $170.48 $1.93 Million - $2.15 Million	-12,593 Reduced 7.79%	149,155 $24.5 Million
Q4 2020 Jan 27, 2021	BUY	$137.11 - $157.38 $2.92 Million - $3.35 Million	21,265 Added 15.14%	161,748 $25.5 Million
Q3 2020 Oct 26, 2020	BUY	$140.38 - $153.83 $411,032 - $450,414	2,928 Added 2.13%	140,483 $20.9 Million
Q2 2020 Jul 23, 2020	SELL	$128.81 - $155.51 $720,176 - $869,456	-5,591 Reduced 3.91%	137,555 $19.3 Million
Q1 2020 Apr 16, 2020	BUY	$111.14 - $153.99 $2.23 Million - $3.09 Million	20,096 Added 16.33%	143,146 $18.8 Million
Q4 2019 Jan 22, 2020	BUY	$127.5 - $146.44 $1.16 Million - $1.33 Million	9,074 Added 7.96%	123,050 $17.9 Million
Q3 2019 Oct 24, 2019	BUY	$126.95 - $142.14 $342,765 - $383,777	2,700 Added 2.43%	113,976 $14.7 Million
Q2 2019 Jul 19, 2019	BUY	$131.15 - $144.24 $174,298 - $191,694	1,329 Added 1.21%	111,276 $15.5 Million
Q1 2019 Apr 29, 2019	BUY	$125.72 - $139.79 $792,161 - $880,816	6,301 Added 6.08%	109,947 $15.4 Million
Q4 2018 Jan 28, 2019	BUY	$122.84 - $147.84 $142,125 - $171,050	1,157 Added 1.13%	103,646 $13.4 Million
Q3 2018 Oct 29, 2018	BUY	$121.58 - $142.88 $159,391 - $187,315	1,311 Added 1.3%	102,489 $14.2 Million
Q2 2018 Jul 24, 2018	BUY	$119.4 - $131.76 $2.65 Million - $2.93 Million	22,201 Added 28.11%	101,178 $12.3 Million
Q1 2018 Apr 17, 2018	BUY	$125.1 - $148.14 $1.36 Million - $1.61 Million	10,837 Added 15.9%	78,977 $10.1 Million
Q4 2017 Jan 23, 2018	BUY	$131.22 - $143.62 $77,551 - $84,879	591 Added 0.87%	68,140 $9.52 Million
Q3 2017 Nov 01, 2017	BUY	$129.47 - $135.38 $8.75 Million - $9.14 Million	67,549	67,549 $8.78 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Johnson & Johnson Transaction History